ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.053 GBX | +0.54% |
|
+4.19% | +1.14% |
Investment objective
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 418.8 USD | +2.09% | +4.15% | +2.93% | 8.46% | ||
| 955.8 USD | -1.46% | +5.79% | +8.82% | 7.85% | ||
| 307.3 USD | +2.33% | +10.79% | +6.70% | 7.84% | ||
| 64.92 USD | -0.82% | -0.90% | -19.86% | 7.77% | ||
| 219.7 USD | +0.37% | +1.66% | -15.09% | 3.86% | ||
| 121.9 USD | +0.68% | +9.36% | +22.56% | 3.85% | ||
| 152.3 USD | -1.32% | +1.55% | -20.44% | 2.51% | ||
| 110.6 USD | -1.95% | -11.28% | -20.55% | 2.31% | ||
| 81.83 USD | -0.91% | -1.80% | -15.13% | 1.87% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/05/24 | 5.053 | +0.54% | 0 |
| 07/05/24 | 5.026 | -1.08% | 0 |
| 06/05/24 | 5.081 | +3.21% | 0 |
| 03/05/24 | 4.923 | +1.59% | 0 |
| 02/05/24 | 4.846 | -0.08% | 0 |
Other stock markets
Delayed Quote Swiss Exchange
Last update May 08, 2024 at 04:55 am
More quotesDescription
| IE00BYXG2H39 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | NASDAQ Biotechnology Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
18/10/2017
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 29/04/2024 )
| AuM (EUR) | 0 M€ |
|---|---|
| AuM 1M | 0 M€ |
| AuM 3 months | 0 M€ |
| AuM 6 months | 0 M€ |
| AuM 12 months | 0 M€ |
- Stock Market
- ETF
- BTEC ETF
